Definitive Contract 75N95019C00060
Award Date
9/25/19
Potential Completion Date
3/31/20
Potential Value
$225K
Federal Agency
National Institute on Drug Abuse
Awardee
B & W TEK Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE 19713, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $1,494,724.00 Small Business Technology Transfer (STTR) Phase II contract to B & W TEK Inc., a for-profit manufacturer. The contract is for the development and testing of an advanced system for safely detecting, neutralizing, and disposing of controlled substance pharmaceutical waste. This is a follow-on effort to a previous $224,656.02 SBIR Phase I...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Portable Diagnostic Systems Inc. in Robbinsville, New Jersey. The contract, with a potential value of $400,000.00, is for the development of an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. The period of performance is September 27, 2023 to September 26, 2024, and the...
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $11,685 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The firm fixed price contract is to provide research and development systems in support of NIH/NIDA programs addressing substance abuse and addiction. Performance will take place in Minneapolis over a two week period concluding on August 1, 2023. No subcontractors or set aside designations were...
This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $279,993.00, was awarded to We The Village, Inc., a for-profit organization, to develop a scalable digital platform for delivering evidence-based training to families to increase treatment admission rates for loved ones with opioid use...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,791.66 firm fixed-price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, for the delivery of a Custom SimplePlex Assay Panel (SPCKE-PS-010046 SPCKE-08). Performance will take place in Baltimore, Maryland through September 2024. The contract calls for Proteinsimple to provide their proprietary assay panel and related services...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Definitive Contract to Biocloud Inc., a self-certified small disadvantaged business, for Small Business Innovative Research (SBIR) support services. The contract has a period of performance from June 27, 2017 to June 26, 2018, with two option periods, and a potential total value of $541,333.92. The place of performance is Gaithersburg, Maryland. This contract...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health, National Institute on Drug Abuse to F3 Healthcare LLC, a for-profit organization. The $210,060.00 contract is for a project to reduce opioid overprescribing by collecting patient-reported outcomes and establishing empirically-informed standard prescribing order sets. The contract was awarded on September 24, 2019 and has a completion date of April 25, 2022. The place of...
This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
This federal contract award, with the ID HHSN271201500074A, was issued by the National Institute on Drug Abuse, a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $149,500.00, was awarded to Bioptix Diagnostics, Inc., a for-profit manufacturer, for the provision of a surface plasmon resonance instrument. The contract is a firm fixed-price purchase order with a completion date of September 24, 2016. It is designated as a total small business...